鱼精蛋白与雄性生殖

鱼精蛋白(protamine,PRM)是精细胞中主要的核蛋白,存在于精子头部,对精子DNA的正确包裹和精子正常功能的维持至关重要。近年研究表明,PRM主要存在PRM1、PRM2、PRM3等3种基因,它们的变异是引发精子生物学异常的重要原因,因此,PRM基因可作为候选基因阐述相关雄性先天性不育的病因。主要阐述PRM的进化和功能及在DNA、RNA和蛋白质水平上PRM与雄性不育的关系,为了解雄性生殖疾病的发生提供理论依据。     

前列腺素与雄性生殖生理

小剂量前列腺素(PGs)作用于下丘脑,增加LHRH释放,后者促使垂体分泌LH、FSH,从而刺激睾酮分泌。睾丸间质细胞的功能还直接受PGs的调节,睾酮也显著影响雄性生殖道中PGs水平。PGs可增加大鼠睾丸重量,刺激生精过程,增加精子细胞数目,提高精子活力,维持生殖道中平滑肌的收缩,参与射精过程,促进精子在雌体生殖道内的运行,故利于受精。大剂量PGs抑制雄性生殖,使血中LH、FSH、睾酮水平下降,使睾丸动脉收缩,导致睾丸萎缩,减少睾丸及副性腺的重量,抑制生精作用,降低附睾精子活力,增加畸精率。     

前列腺素与雄性生殖生理

小剂量前列腺素(PGs)作用于下丘脑,增加LHRH释放,后者促使垂体分泌LH、FSH,从而刺激睾酮分泌。睾丸间质细胞的功能还直接受PGs的调节,睾酮也显著影响雄性生殖道中PGs水平。PGs可增加大鼠睾丸重量,刺激生精过程,增加精子细胞数目,提高精子活力,维持生殖道中平滑肌的收缩,参与射精过程,促进精子在雌体生殖道内的运行,故利于受精。大剂量PGs抑制雄性生殖,使血中LH、FSH、睾酮水平下降,使睾丸动脉收缩,导致睾丸萎缩,减少睾丸及副性腺的重量,抑制生精作用,降低附睾精子活力,增加畸精率。     

高效液相色谱法测定碳酸钙D_3咀嚼片中维生素D_3的含量

目的:建立高效液相色谱法测定碳酸钙D3咀嚼片中维生素D3含量的方法。方法:采用高效液相色谱法。以Diamonsil C18(250 mm×4.6mm,5μm)为色谱柱;流动相为甲醇;流速:1.0 ml·min-1;检测波长:264 nm。结果:维生素D3在4.8~38.4μg范围内。进样量与峰面积线性关系良好(r=1.0)。平均回收率为:97.82%(RSD=1.15%)。结论:方法简便、快速准确、灵敏度高,重现性好。可作为碳酸钙D3咀嚼片的质量控制方法。     

内质网应激与哺乳动物雄性生殖

内质网应激 (endoplasmic reticulum stress,ERS) 激活未折叠蛋白反应,维持哺乳动物细胞的胞内稳态,过度持续的ERS导致细胞凋亡。最新研究表明,ERS对哺乳动物雄性生殖有重要的调节作用,包括对精母细胞、睾丸结构及精子发生的影响。ERS是研究生殖细胞生存和凋亡的新通路。雄性不育可能是由过度ERS引起的。本文通过简述ERS的最新研究进展,分析雄性生殖与ERS的关系,并从ERS调控雄性生殖角度提出新的理解和展望。     

维生素C对中华绒螯蟹雄性生殖的影响

采用不同Vc的人工配合饲料 ,研究了Vc对中华绒螯蟹雄性生殖的影响。实验分为 5组 ,其添加量分别为 0mg 1 0 0g饲料 (实验 1组 )、2 0 0mg 1 0 0g饲料 (实验 2组 )、40 0mg 1 0 0g饲料 (实验 3组 )、60 0mg 1 0 0g饲料 (实验 4组 )和 80 0mg 1 0 0g饲料 (实验 5组 ) ,实验为期 5 0d。结果如下 :1 )肝胰腺、精巢和副性腺中Vc的积累量以实验 3组最高 ,分别为 2 2 61 μg mgprot、1 0 2 1 7μg mgprot、7 661 μg mgprot;2 )肝体指数和性腺指数以实验 3组最高 ,分别为 0 0 5 2 3和 0 0 2 68;3 )增重率同样以实验 3组最高 ,实验 1组最低 ,分别为 3 1 3 3 %和 2 1 2 %;4)睾酮含量以实验 2组最高 ,为 1 2 5 7ng ml,但实验 3组的睾酮含量与实验 2组接近 ;5 )SOD酶活性与其Vc含量呈负相关 ,且精巢和副性腺的酶活性高于肝胰腺。结果表明 :适量添加Vc可促进雄蟹肝胰腺、精巢和副性腺对Vc的积累 ,同时可促进精巢的发育及睾酮的分泌 ,而过量添加可能会对精巢的发育产生不良影响 ;河蟹体内的抗氧化系统之间存在着相互的协调和平衡 ,生殖期性腺对其自身的抗氧化保护需求要高于其它组织     

微生物转化制备活性维生素D_3的研究进展

活性维生素D类药物作为一类高效原料药,采用化学合成方法,制备复杂,限制了其广泛应用。采用微生物转化法条件温和,操作简单,对于活性维生素D3的制备具有重要意义。从甾体羟化菌株,生物转化制备不同活性维生素D3、基因工程在生物转化上的应用及转化率的影响因素等方面综述了其研究进展,并对该领域的发展趋势进行了展望。     

被子植物的雄性生殖单位

一粒被子植物的成熟花粉,外面是壁,其内包含着一个营养细胞和一个生殖细胞或两个精子。八十年代以前,由于受实验条件的限制,人们未能观察到成熟花粉内营养核和生殖细胞或营养核和两个精子之间存在着联系。近年来,随着现代科学技术的不断发展,特别是电镜技术和电子计算机技术的发展,人们对于植物的生殖过程进行了比较深入地研究。发现某些植物的成熟花粉中,营养核和生殖细胞或营养核与两个精子之间存在着密切联系。从而提出了“雄性生殖单位”的概念。被子植物的一对精子和营养核或生殖细胞和营养核,构成一个功能复合体,叫做“雄性生     

维生素D_3及其类似物调控细胞生长分化的可能机制

维生素Ｄ3 是一种脂溶性维生素 ,其活性形式是 1α ,2 5 (ＯＨ) 2 Ｄ3 。它除了分布于传统的靶组织如肠、成骨细胞、肾远曲小管外 ,亦分布于许多非经典的靶组织细胞中 ,如造血组织、神经肌肉组织、生殖细胞以及免疫细胞等 ,这强烈提示 1α ,2 5 (ＯＨ) 2 Ｄ3 具有更多的其它生物效应[1] 。现已清楚 ,1α ,2 5 (ＯＨ) 2 Ｄ3除了能调节钙磷代谢和免疫系统的功能外 ,还能调控多种组织来源的正常细胞和肿瘤细胞的生长和分化 ,主要表现为抑制细胞的增殖和促进细胞分化[2～ 4] 。然而其分子机制并不完全清楚。本文就维生素Ｄ3 及其类似物调节细胞…     

1，25－二羟维生素D_3的免疫调节作用

１,２５（ＯＨ）２Ｄ３是维生素Ｄ３的激素形式,其生物效应是由１,２５（ＯＨ）２Ｄ３受体（ＶＤＲ）介导的。单核细胞、激活的淋巴细胞等免疫系统细胞均有ＶＤＲ的表达,１,２５（ＯＨ）２Ｄ３对免疫系统功能有重要调节作用,主要表现于：在分子水平上抑制白细胞介素２（ＩＬ２）、γ－干扰素（ＩＮＦ－γ）及粒单系集落刺激因子（ＧＭ－ＣＳＦ）等细胞因子的表达;在细胞水平上调节免疫系统细胞的增殖分化及其免疫功能;在整体水平上可以减少实验性自身免疫性疾病的发病率并改善病情,并能延长实验性移植器官的存活时间。     

Vitamin D Deficiency Reduces Vascular Reactivity of Coronary Arterioles in Male Rats

Background: Vitamin D deficiency (VDD) may be considered an independent cardiovascular (CV) risk factor, and it is well known that CV risk is higher in males. Our goal was to investigate the pharmacological reactivity and receptor expression of intramural coronary artery segments of male rats in cases of different vitamin D supply. Methods: Four-week-old male Wistar rats were divided into a control group (n = 11) with optimal vitamin D supply (300 IU/kgbw/day) and a VDD group (n = 11, <0.5 IU/kgbw/day). After 8 weeks of treatment, intramural coronary artery segments were microprepared, their pharmacological reactivity was examined by in vitro microangiometry, and their receptor expression was investigated by immunohistochemistry. Results: Thromboxane A₂ (TXA₂)-agonist induced reduced vasoconstriction, testosterone (T) and 17-β-estradiol (E2) relaxations were significantly decreased, a significant decrease in thromboxane receptor (TP) expression was shown, and the reduction in estrogen receptor-α (ERα) expression was on the border of significance in the VDD group. Conclusions: VD-deficient male coronary arteries showed deteriorated pharmacological reactivity to TXA₂ and sexual steroids (E2, T). Insufficient vasoconstrictor capacity was accompanied by decreased TP receptor expression, and vasodilator impairments were mainly functional. The decrease in vasoconstrictor and vasodilator responses results in narrowed adaptational range of coronaries, causing inadequate coronary perfusion that might contribute to the increased CV risk in VDD.     

Investigating Transdermal Delivery of Vitamin D3

Transdermal delivery of therapeutic amounts of vitamin D₃ is proposed to overcome its variable oral bioavailability, especially for people who suffer from fat malabsorption. The main challenge for this delivery route is to overcome the barrier properties of skin, especially for very lipophilic compounds such as vitamin D₃. In this study, the effect of different penetration enhancers, such as oleic acid, dodecylamine, ethanol, oleic acid in propylene glycol, isopropyl myristate, octyldodecanol, and oleyl alcohol in propylene glycol were evaluated in vitro for their effectiveness in delivering vitamin D₃ through polyamide filter, polydimethylsiloxane membrane, and porcine skin. A diffusion cell was used to study the transdermal permeability of vitamin D₃. Ointment formulations of vitamin D₃ were prepared containing the most widely used penetration enhancers, oleic acid, and dodecylamine. The ointment containing oleic acid as chemical penetration enhancer did not improve delivery compared to control. On the other hand, the formulation containing dodecylamine as a penetration enhancer did improve the transdermal delivery of vitamin D₃. However, statistical significance and an amount high enough for nutritional supplementation purposes were reached only when the skin was pretreated with 50% ethanol. In these conditions, the ointment delivered an amount of 760-ng vitamin D₃ per cm² of skin. The research shows promise that transdermal delivery could be an effective administration route for vitamin D₃ when ethanol and dodecylamine are used as penetration enhancers.KEY WORDS: dodecylamine, ethanol, penetration enhancer, transdermal delivery, vitamin D₃     

Vitamin D3-implications for brain development

There is growing evidence that 1,25-dihydroxyvitamin D(3) (1,25(OH)(2)D(3)) is active in the brain but until recently there was a lack of evidence about its role during brain development. Guided by certain features of the epidemiology of schizophrenia, our group has explored the role of 1,25(OH)(2)D(3) in brain development using whole animal models and in vitro culture studies. The expression of the vitamin D receptor (VDR) in the embryonic rat brain rises steadily between embryonic day 15-23, and 1,25(OH)(2)D(3) induces the expression of nerve growth factor and stimulates neurite outgrowth in embryonic hippocampal explant cultures. In the neonatal rat, low prenatal vitamin D(3) in utero leads to increased brain size, altered brain shape, enlarged ventricles, reduced expression of nerve growth factors, reduced expression of the low affinity p75 receptor and increased cellular proliferation. In summary, there is growing evidence that low prenatal levels of 1,25(OH)(2)D(3) can influence critical components of orderly brain development. It remains to be seen if these processes are of clinical relevance in humans, but in light of the high rates of hypovitaminosis D in pregnant women and neonates, this area warrants further scrutiny.     

Vitamin D Metabolism and Guidelines for Vitamin D Supplementation

Vitamin D is essential for bone health and is known to be involved in immunomodulation and cell proliferation. Vitamin D status remains a significant health issue worldwide. However, there has been no clear consensus on vitamin D deficiency and its measurement in serum, and clinical practice of vitamin D deficiency treatment remains inconsistent. The major circulating metabolite of vitamin D, 25-hydroxyvitamin D (25(OH)D), is widely used as a biomarker of vitamin D status. Other metabolic pathways are recognised as important to vitamin D function and measurement of other metabolites may become important in the future. The utility of free 25(OH)D rather than total 25(OH)D needs further assessment. Data used to estimate the vitamin D intake required to achieve a serum 25(OH)D concentration were drawn from individual studies which reported dose-response data. The studies differ in their choice of subjects, dose of vitamin D, frequency of dosing regimen and methods used for the measurement of 25(OH)D concentration. Baseline 25(OH)D, body mass index, ethnicity, type of vitamin D (D₂ or D₃) and genetics affect the response of serum 25(OH)D to vitamin D supplementation. The diversity of opinions that exist on this topic are reflected in the guidelines. Government and scientific societies have published their recommendations for vitamin D intake which vary from 400–1000 IU/d (10–25 μg/d) for an average adult. It was not possible to establish a range of serum 25(OH)D concentrations associated with selected non-musculoskeletal health outcomes. To recommend treatment targets, future studies need to be on infants, children, pregnant and lactating women.     

Effects of pharmacological doses of Vitamin D3 on mineral balance and profiles of plasma Vitamin D3 metabolites in horses

Metabolism and functions of Vitamin D in horses differ from those in humans, pigs and rats. In horses, calcidiol and calcitriol concentrations in blood plasma are remarkably low (<10 nmol L(-1); 20-40 pmol L(-1), respectively). When a toxic amount of Vitamin D(3) is administered, the responsiveness of calcium and calcitriol concentrations in blood plasma is much reduced compared to the other domestic animal species but inorganic phosphate (Pi) response is much more marked, leading to an increase of the Ca x Pi product. Also, soft tissue calcifications have been observed to develop in horses during Vitamin D(3) intoxication. It was suggested that the elevation of the Ca x Pi product may play a causative role in this calcification process. To test this assumption, two horses were treated with 40,000 IU kg(-1) of Vitamin D(3) whilst dietary uptake of Ca and Pi was restricted to prevent or to diminish the increase of the Ca x Pi product. Distribution, number and severity of calcification centres were considerably less in these horses than in the control animals of a previous experiment which had received the same amount of Vitamin D(3) but where Ca and Pi intake was not restricted. It appears from these findings that in horses, the increase of the Ca x Pi product in blood plasma during a Vitamin D intoxication contributes to the soft tissue calcifications. It is further concluded that in the event of a Vitamin D intoxication, it is recommended to restrict the Ca and Pi uptake immediately. The authors believe that this may help to prevent or at least diminish soft tissue calcifications which are often fatal to the horse due to nephrocalcinosis.     

Vitamin D3 and calcium absorption in the chick

1. An attempt has been made to locate the site of action of vitamin D(3) as it affects the translocation of calcium across the intestine. 2. Calcium appears to be pumped out of cells by a process dependent on energy from metabolism. 3. The effects of cold, inhibitors and vitamin D(3) on the translocation of calcium by everted sacs of intestine were studied and compared with results obtained in vivo. 4. A model was proposed to explain the results which suggests that vitamin D(3) inhibits a metabolically operated pump that returns calcium from the mucosal cell to the lumen. 5. Some observations on the effect of sodium lauryl sulphate on the translocation of calcium in vivo and in vitro are reported.